Naomi C. Sacks, Ph.D.
Principal Scientist


Phone(617) 872-5474
Address1451 Rockville Pike
Suite 250
Rockville, MD 20852




Professional Profile

Dr. Naomi Sacks is a health economics and outcomes researcher who brings to EpidStrategies a three-decade career in both academia and the private sector. In recent years, she has led research on emerging and current therapies for pharmaceutical, biotech, and medical device clients. She works closely with clients to quantify healthcare resource use and costs, treatment patterns, and clinical outcomes in rare and ultra rare diseases, as well as more prevalent diseases. Her expertise with data sources includes experience with unadjudicated (PurpleLab, IQVIA) and adjudicated (PharMetrics Plus, Optum Clinformatics, MarketScan) claims, longitudinal prescription drug data (IQVIA’s LRx), electronic medical records (EMR), and registry, clinical trial, and chart review data. Dr. Sacks has worked with US and EU data sources and has led data landscape and evidence strategy assessments. In a previous private-sector engagement as an analytic operations consultant and senior manager, she led and managed multiple analytic projects using the PharMetrics Plus database and Health National Prescription Audit (NPA) data sources. Health plan claims output included risk assessment, generated using DxCG and other risk adjustment tools, and disease identification and episode grouping based on Symmetry Episode Treatment Groups (ETGs).

In the academic arena, Dr. Sacks is an adjunct faculty member in Public Health and Community Medicine at Tufts University (Boston), which has included service as the Course Director for the Health Economics full-semester course. She has also been an instructor and project director in the Department of Quantitative Health Sciences, University of Massachusetts (Worcester), a teaching assistant at the Boston University School of Health, and a research assistant, helping with a book on child health advocacy.